Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Dlbcl Clinical'

Dlbcl Clinical published presentations and documents on DocSlides.

Update in Hodgkins & DLBCL
Update in Hodgkins & DLBCL
by debby-jeon
Andy Chen, MD PhD. Center for Hematologic Maligna...
Burhan Ferhanoglu M.D.
Burhan Ferhanoglu M.D.
by kittie-lecroy
Koç University Medical School Istanbul/Turkey. ...
Updates in Diffuse Large B-Cell Lymphoma
Updates in Diffuse Large B-Cell Lymphoma
by sherrill-nordquist
Program Goals. DLBCL Subtypes . 2008 WHO Classifi...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma
by reagan
November 10, 2021. Course Director. John P. Leonar...
Changes in Life Expectation for Diffuse Large
Changes in Life Expectation for Diffuse Large
by roberts
B-Cell . Lymphoma (DLBCL) Patients, . 1983 . – 2...
Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
by isabella2
Dr. Gilles SALLES. Chief . of. . the. . Lymphoma...
MYC/BCL2 protein coexpression
MYC/BCL2 protein coexpression
by Ziggystardust
contributes inferior outcome in DLBCL . ...
How To Get Lymphoma Patients To CAR-T Therapy In The UK
How To Get Lymphoma Patients To CAR-T Therapy In The UK
by vivian
Dr. Sanne Lugthart. (. Dr. Stephen Robinson). Un...
1 DLBCL of the elderly in age older than life expectancy
1 DLBCL of the elderly in age older than life expectancy
by tabitha
the single institute experience in Taiwan . Sheng...
Translating the biology of diffuse large B-cell lymphoma into treatment
Translating the biology of diffuse large B-cell lymphoma into treatment
by callie
Prof. . Alexey V. Danilov, MD, PhD,. 1. Dr. Massi...
Treatment Of Later Relapse/ Chemo-Resistant
Treatment Of Later Relapse/ Chemo-Resistant
by ida
Diffuse Large B Cell Lymphoma. Foroud. . shahbazi...
Recent developments in the treatment of DLBCL
Recent developments in the treatment of DLBCL
by payton
Prof. Georg Lenz, MD. Department of Haematology, O...
Novel genetic subgroups inform on shared pathobiology within adult and pediatric Burkitt lymphoma
Novel genetic subgroups inform on shared pathobiology within adult and pediatric Burkitt lymphoma
by madison
Nicole Thomas. Morin Lab. SFU. Burnaby, BC, Canada...
MYC-associated and Double Hit
MYC-associated and Double Hit
by myesha-ticknor
L. ymphomas. Lisa G Roth, MD. Division of Hematol...
CAR-T Therapy in non-Hodgkin lymphomas
CAR-T Therapy in non-Hodgkin lymphomas
by natalie
Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
ESMO-Recommendations-Covid-19-DLBCL-MCL-ATCL-Slide-Set
ESMO-Recommendations-Covid-19-DLBCL-MCL-ATCL-Slide-Set
by bitsy
NON-HODGKINS LYMPHOMA DR. SANJANA BHAGWAT
NON-HODGKINS LYMPHOMA DR. SANJANA BHAGWAT
by DreamGirl
MODERATOR : DR. GANAPULE . Definition . Lymphomas ...
MALT GASTRIC LYMPHOMA
MALT GASTRIC LYMPHOMA
by adia
1 AN UPDATE OF PATHOGENETIC FEATURES WCRJ 2016; 3 ...
Understanding Lymphoma Series
Understanding Lymphoma Series
by evans
Helpline: 800 500 9976 | helpline@lymphoma.org U...
HIGH GRADE B
HIGH GRADE B
by luna
- CELL LYMPHOMA DAVID NOLTE, MD (PGY - 2) HUSSAM...
Jeremy Abramson, MD Director, Lymphoma Program
Jeremy Abramson, MD Director, Lymphoma Program
by natalie
Jon and Jo Ann Hagler Chair in Lymphoma. Massachus...